Upgrade to SI Premium - Free Trial

Moderna (MRNA) PT Raised to $25 at Wolfe Research

July 20, 2026 5:34 AM
Wolfe Research analyst Alexandria Hammond raised the price target on Moderna (NASDAQ: MRNA) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change